
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
Scientists may be able to minimize adverse effects while gaining a better understanding of psychedelic medicines' efficacy and durability.
This month, we spoke with Joseph Araujo, co-founder, director, and chief scientific officer at Mindset Pharma, to get an overview of the differences between synthetic and natural psychedelic medicines. By developing synthetic versions of natural medicines, scientists may be able to minimize adverse effects while gaining a better understanding of their efficacy and durability.






